Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 13 (4) , 223-231
- https://doi.org/10.3109/00498258309052258
Abstract
1. The influence of pretreatment of rats with 9-hydroxyellipticine and 3-methylcholanthrene on different enzymes of the hepatic mixed-function oxidase system were studied using antipyrine as model compound. Antipyrine half-lives and clearances were estimated in blood, and the metabolite profile was determined in urine. 2. 3-Methylcholanthrene treatment resulted in an increase in antipyrine clearance from 17 to 75 ml/min per kg. Partial clearance of formation of 4-hydroxyantipyrine was selectively increased from 3.9 to 28.2 ml/min kg, whereas clearance of 3-hydroxymethyl-antipyrine was decreased from 3.2 to 1.2 ml/min per kg. Norantipyrine formation was increased from 2.7 to 7.2 ml/min per kg, while 4,4′-dihydroxyantipyrine formation was unchanged. 3. 9-Hydroxyellipticine treatment resulted in no change in the total clearance, and only the clearance of 4,4′-dihydroxyantipyrine was decreased, from 2.5 to 1.5 ml/min per kg. After pretreatment with 3-methylcholanthrene, 9-hydroxyellipticine treatment resulted in a selective decrease in the clearances of 4-hydroxyantipyrine, from 28.2 to 15.8 ml/min per kg, and of 4,4′-hydroxyantipyrine, from 3.8 to 1.6 ml/min per kg. 4. From these results it is concluded, that 9-hydroxyellipticine is a selective inhibitor of the activity of some of the cytochrome P-450s involved in antipyrine metabolism, though this inhibition does not effect all of these enzymes, nor is it restricted to polycyclic hydrocarbon-induced activity. 5. These results further substantiate the value of antipyrine as a model substrate, for they indicate that the formation of all four metabolites of antipyrine in rats is mediated by different (iso-)enzymes.This publication has 14 references indexed in Scilit:
- Quantitation and urinary pattern of 4,4′-dihydroxyantipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and ratJournal of Pharmacy and Pharmacology, 1982
- 3-Hydroxymethyl Antipyrine Excretion in Urine after an Oral Dose of AntipyrinePharmacology, 1982
- Selective Induction of Two Different Molecular Species of Cytochrome P-450 by Phenobarbital and 3-MethylcholanthreneThe Journal of Biochemistry, 1981
- Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicityBiochemical Pharmacology, 1980
- Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to ratsChemico-Biological Interactions, 1980
- Antipyrine metabolism in the rat by three hepatic monooxygenasesLife Sciences, 1980
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: Their binding to microsomal cytochromes p450 and protective effect against benzo(a)pyrene mutagenicityBiochemical Pharmacology, 1978
- III. Ueber des 1‐Phenyl‐2,3 ‐dimethyl‐4‐oxy‐5‐ pyrazolon1) (4‐Oxyantipyrin)European Journal of Organic Chemistry, 1896